Canopy Growth Corp
Canopy Growth Corp is a Canadian cannabis company that cultivates, produces, and sells cannabis and cannabis-derived products for medical and recreational use.
Business. Canopy Growth Corp (WEED.TO) is a healthcare company operating within the pharmaceuticals and medical research industry. The firm generates revenue through a product-sale model, focusing on activities related to pharmaceuticals and medical research. Headquartered in Canada, the company is primarily listed on the Toronto Stock Exchange under the ticker WEED.TO. Specific details regarding operating segments and geographic revenue mix are not available.
Analyst recommendations
6 analysts · consensus HoldAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Canopy Growth Corp (WEED.TO) has entered the analytical scope for the first time, establishing a baseline for future monitoring. As this is the initial analysis for the ticker, there is no prior data to compute material changes or deltas, meaning current observations serve as the foundational reference point for the company's financial and operational profile. The most notable activity involves a major severity signal regarding a holder change for investor ID 587. Data detected on June 20, 2026, indicates a modification in shareholding from 9 shares to 610 shares as of March 31, 2026. This was followed by a subsequent modification detected on June 21, 2026, showing the position reverting from 610 shares back to 9 shares for the same reporting period. These rapid, conflicting adjustments in the same investor's reported holdings highlight significant data volatility or correction activity within the shareholder registry. Despite these holder fluctuations, the broader institutional landscape remains sparse. Canopy Growth currently has only one analyst covering the stock and zero index memberships, suggesting limited mainstream financial integration. The company maintains a top holder count of 11, but the specific details of these major stakeholders are not fully elaborated beyond the anomalous activity of investor ID 587. This initial snapshot underscores the importance of data verification for Canopy Growth, particularly given the erratic reporting from a single investor. With no cross-source signals or sagas to provide additional context, the current view is defined by this lack of historical comparison and the specific, volatile holder changes. Investors should monitor whether these data corrections stabilize as more comprehensive financial, estimate, and ESG data becomes available.
Signals & dispatch
Composite-score breakdown
Synthesis
Canopy Growth Corp (WEED.TO) is a healthcare company operating within the pharmaceuticals and medical research industry. The firm generates revenue through a product-sale model, focusing on activities related to pharmaceuticals and medical research. Headquartered in Canada, the company is primarily listed on the Toronto Stock Exchange under the ticker WEED.TO. Specific details regarding operating segments and geographic revenue mix are not available.
Canopy Growth Corp has a debt-to-equity ratio of 0.67 and a current ratio of 3.12, indicating moderate leverage and strong short-term liquidity. However, the company's cash and equivalents amount to only CAD 130,000, which is significantly lower than its long-term debt of CAD 325,267,000, suggesting a liquidity risk.
The company's profitability metrics are weak, with a return on equity of -1.2276 and a return on assets of -0.6518, both well below the industry median for pharmaceutical companies. These figures indicate that the company is not generating returns for shareholders or effectively utilizing its assets.
Canopy Growth Corp's revenue is concentrated in a single business segment, cannabis cultivation and sales, with no disclosed geographic diversification. This concentration increases exposure to regulatory and market risks in the cannabis industry.
The company's growth trajectory is uncertain, with no disclosed revenue growth in the most recent fiscal year. Analysts have provided a mean price target of CAD 2.36 and a median price target of CAD 1.80, with a mean recommendation of 2.83, indicating a mixed outlook.
The company's risk assessment highlights a medium liquidity risk and a low dilution risk. The key flag of negative net cash after subtracting total debt underscores the company's financial vulnerability.
Recent events include a continued focus on cost reduction and operational efficiency, as disclosed in the company's latest financial filings. No major new product launches or strategic acquisitions were reported in the most recent quarter.
Canopy Growth Corp (WEED.TO) has entered the analytical scope for the first time, establishing a baseline for future monitoring. As this is the initial analysis for the ticker, there is no prior data to compute material changes or deltas, meaning current observations serve as the foundational reference point for the company's financial and operational profile. The most notable activity involves a major severity signal regarding a holder change for investor ID 587. Data detected on June 20, 2026, indicates a modification in shareholding from 9 shares to 610 shares as of March 31, 2026. This was followed by a subsequent modification detected on June 21, 2026, showing the position reverting from 610 shares back to 9 shares for the same reporting period. These rapid, conflicting adjustments in the same investor's reported holdings highlight significant data volatility or correction activity within the shareholder registry. Despite these holder fluctuations, the broader institutional landscape remains sparse. Canopy Growth currently has only one analyst covering the stock and zero index memberships, suggesting limited mainstream financial integration. The company maintains a top holder count of 11, but the specific details of these major stakeholders are not fully elaborated beyond the anomalous activity of investor ID 587. This initial snapshot underscores the importance of data verification for Canopy Growth, particularly given the erratic reporting from a single investor. With no cross-source signals or sagas to provide additional context, the current view is defined by this lack of historical comparison and the specific, volatile holder changes. Investors should monitor whether these data corrections stabilize as more comprehensive financial, estimate, and ESG data becomes available.
- Canopy Growth Corp has a weak return on equity and return on assets, indicating poor profitability.
- The company's liquidity is constrained by low cash reserves relative to its debt.
- Revenue is concentrated in a single business segment, increasing exposure to industry-specific risks.
- Analysts have a mixed outlook, with a mean price target of CAD 2.36 and a median price target of CAD 1.80.
- The company faces a medium liquidity risk and a low dilution risk.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | -0,47 |
| Revenue | —no estimate | —no estimate | 285,5M CAD |
| Operating income | —no estimate | —no estimate | -80,5M CAD |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Canopy Growth Corp Market data — financials · 2026-05-30
- Canopy Growth Corp Market data — analyst estimates · 2026-05-30
- Canopy Growth Corp Market data — ESG · 2026-05-30
Ownership & reference
Top holders
- Investment Managers · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$2M
- Investment Managers · as of 2026-03-310,00 %$0M
- Institutional Investor · as of 2026-03-310,00 %$0M
- Institutional Investor · as of 2026-03-310,00 %$0M
- Brokerage Firms · as of 2026-03-310,00 %$0M
- Brokerage Firms · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2024-06-300,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M